Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_3
1
100%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 3Large-scale testing
1(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

1

all time

Status Distribution
Other(1)

Detailed Status

unknown1

Development Timeline

Analytics

Development Status

Total Trials
1
Active
0
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 31 (100.0%)

Trials by Status

unknown1100%

Recent Activity

0 active trials
Showing 1 of 1
unknownphase_3

Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI

NCT03001960

Clinical Trials (1)

Showing 1 of 1 trials
NCT03001960Phase 3

Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI

Unknown

All 1 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
1